Ozempic is an FDA-approved prescription medication for the treatment of type ... events like stroke or heart attack. The active compound in Ozempic, semaglutide, is a glucagon-like peptide-1 ...

Semaglutide belongs to a class of prescription medications that mimic a hormone your body naturally produces after you eat. This hormone helps your pancreas make insulin, which lowers your blood sugar ...

Population and animal studies suggested it could treat cancer, but the clinical trials were a bust. Here’s what happened and ...

A highly effective class of weight loss drug has taken the world by storm, as medications like Ozempic, Wegovy, and Zepbound become household names. These drugs, originally meant to treat diabetes, ...

A trade group representing compounding pharmacies sued the FDA for a “reckless and arbitrary” decision to remove Eli Lilly's ...

A drug compounding industry group on Monday sued the U.S. Food and Drug Administration over its decision to take Eli Lilly’s ...

Some oncologists are turning to GLP-1 agents to help patients shed excess pounds, with the goal of improving cancer outcomes.

Additionally, it is important to note that the FDA does not approve compounded versions of GLP-1 drugs, which some telehealth companies will offer. In fact, the FDA does not recommend people use ...

Glucagon-like peptide 1 receptor agonists, more commonly known as GLP-1 medications, have dominated headlines for their ...

Septerna, Inc. aims to raise $100 million in an IPO to advance its clinical-stage biopharma treatments for endocrine diseases ...

WeightWatchers said on Tuesday it would offer compounded form of Novo Nordisk's popular obesity drug Wegovy as part of its ...

Ninety percent say the FDA should use their existing authority to ensure these compounded weight loss drugs are safe. Compounded medicines serve an important role in the U.S. healthcare system ...